References
- Ermann J, Fathman CG. Autoimmune diseases: Genes, bugs and failed regulation. Nat Immunol. 2001; 2 9: 759–761.
- Noorchashm H, Greeley SAW, Naji A. B-cell deficiency and type 1 diabetes. N Engl J Med. 2002; 346 7: 538–539.
- Lisman JE. A mechanism for memory storage insensitive to molecular turnover: A bistable autophosphorylating kinase. Proc Natl Acad Sci USA. 1985; 82 9: 3055–3057.
- Perelson AS. Modelling viral and immune system dynamics. Nat Rev Immunol. 2002; 2 1: 28–36.
- Wodarz D, Jansen VAA. A dynamical perspective of CTL cross-priming and regulation: Implications for cancer immunology. Immunol Lett. 2003; 86 3: 213–227.
- Borghans JA, De Boer RJ, Sercarz E, Kumar V. T cell vaccination in experimental autoimmune encephalomyelitis: A mathematical model. J Immunol. 1998; 161 3: 1087–1093.
- Iwami S, Takeuchi Y, Miura Y, Sasaki T, Kajiwara T. Dynamical properties of autoimmune disease models: Tolerance, flare-up, dormancy. J Theor Biol. 2007; 246 4: 646–659.
- De Boer RJ. Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus. J Virol. 2007; 81 6: 2838–2848.
- Borghans JA, de Boer RJ, Segel LA. Extending the quasi-steady state approximation by changing variables. Bull Math Biol. 1996; 58 1: 43–63.
- Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007; 356 15: 1517–1526.
- Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin J, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach J-F, Pipeleers D, Chatenoud L. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005; 352 25: 2598–2608.
- Thye T, Scarisbrick G, Browne ENL, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Niemann S, Rüsch-Gerdes S, Meyer CG, Horstmann RD. CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an african population. PLoS One. 2009; 4 7: e6307.
- Jonker M, Bakker K, Slierendregt B, Hart BT, Bontrop R. Autoimmunity in non-human primates: The role of major histocompatibility complex and T cells, and implications for therapy. Human Immunol. 1991; 32 1: 31–40.
- Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Human Immunol. 1999; 60 7: 575–582.
- Faustman DL. MHC class I and autoimmune diabetes. Biomed Pharmacother. 1993; 47 1: 3–10.
- Cheong KY, Allcock RJN, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes. Human Immunol. 2001; 62 12: 1363–1370.
- Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, Charles P, Ding B, Alfredsson L, Padyukov L, Symmons DPM, Venables PJ, Klareskog L, Lundberg K. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet. 2009; 41 12: 1319–1324.
- Vial T, Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology. 1995; 105 1: 31–57.
- Mellergård J, Havarinasab S, Hultman P. Short- and long-term effects of T-cell modulating agents in experimental autoimmunity. Toxicology. 2004; 196 3: 197–209.